Stock Price Quote

LINCOLN PHARMACEUTICALS LTD.

NSE : LINCOLNBSE : 531633ISIN CODE : INE405C01035Industry : Pharmaceuticals & DrugsHouse : Private
BSE348.855.2 (+1.51 %)
PREV CLOSE ( ) 343.65
OPEN PRICE ( ) 346.50
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 10801
TODAY'S LOW / HIGH ( )342.25 353.05
52 WK LOW / HIGH ( )191.05 385.15
NSE348.454.25 (+1.23 %)
PREV CLOSE( ) 344.20
OPEN PRICE ( ) 341.50
BID PRICE (QTY) 348.45 (1715)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 123529
TODAY'S LOW / HIGH( ) 341.15 353.55
52 WK LOW / HIGH ( )190.95 384
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 20-01 1995
Management Info
Kishor M Shah - Chairman Mahendra G Patel - Managing Director
Registered Office

Address Lincoln House", Behind Satyam Complex,Science City Road,Sola,
Ahmedabad,
Gujarat-380060

Phone 079-30018000

Email info@lincolnpharma.com

Website www.lincolnpharma.com

Registrars Details
Link Intime India Pvt Ltd.
506-508, 5th Floor, Amaranth Business Complex - I (ABC - I),Beside Gala Business Center, St. Xaviers Corner, Off C.G. Road,Navrangpura,Ahmedabad
Listing : BSE, NSE, Ahmedabad

NEWS

28Jun Lincoln Pharmaceuticals informs about
Lincoln Pharmaceuticals has informed that the Exchange has received the..
25May Board recommends Dividend
Lincoln Pharmaceuticals Ltd has informed BSE that the Board of Directors..
17May Board Meeting Intimation for Consider
LINCOLN PHARMACEUTICALS LTD.has informed BSE that the meeting of the Boa..
17May Board to consider FY21 results & Divi
Lincoln Pharmaceuticals Ltd has informed BSE that the Meeting of the Boa..
17May Lincoln Pharmaceuticals to hold board
Lincoln Pharmaceuticals has informed that the meeting of the Board of Di..

Financials

in Millions
QTR Mar 21 ANNUAL 21
Net Profit118.5604.06
Gross Profit 147.9 810.12
Operating Profit 167.42881.16
Net Sales 775.414130.55

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Abbott India (BSE)
peergroup  19086.15 (4.92%)
M.Cap ( in Cr)40556.74
Sanofi India (BSE)
peergroup  8367.90 (3.43%)
M.Cap ( in Cr)19271.79
Alkem Laboratories (BSE)
peergroup  3454.55 (3.70%)
M.Cap ( in Cr)41304.33
Sun Pharma Inds. (BSE)
peergroup  774.00 (10.06%)
M.Cap ( in Cr)185708.53
Divi's Lab (BSE)
peergroup  4904.65 (1.20%)
M.Cap ( in Cr)130203.05

Shareholding Pattern

NON-INSTITUTION 62.21%
PROMOTERS 37.78%
FI/BANKS/INSURANCE 0%
MUTUAL FUNDS/UTI 0%
GOVERNMENT 0%
FII 0%

Mf Holdings

Scheme NameHold(%)
No Data Found

About Lincoln Pharmaceuticals Ltd.

Lincoln Pharmaceuticals Ltd. was incorporated in the year 1995. Its today's share price is 348.85. Its current market capitalisation stands at Rs 697.7 Cr. In the latest quarter, company has reported Gross Sales of Rs. 3891.71 Cr and Total Income of Rs.3882.19 Cr. The company's management includes Hashmukhbhai Patel, Niren Atinbhai Desai, Saurin J Parikh, Meha Patel, Pirabhai Suthar, Ishwarlal Patel, Arvind G Patel, Rajnikant G Patel, Ashish Patel, Munjal M Patel, Mahendra G Patel, Kishor M Shah.

It is listed on the BSE with a BSE Code of 531633 , NSE with an NSE Symbol of LINCOLN and ISIN of INE405C01035. It's Registered office is at Lincoln House", Behind Satyam Complex,Science City Road,SolaAhmedabad-380060, Gujarat. Their Registrars are ACC Ltd. It's auditors are Chandulal M Shah & Co, DK Chhajer & Co, JT Shah & Co

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)